as 03-26-2025 4:00pm EST
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one fourth of Stryker's total revenue currently comes from outside the United States.
Founded: | 1941 | Country: | United States |
Employees: | N/A | City: | PORTAGE |
Market Cap: | 141.0B | IPO Year: | N/A |
Target Price: | $420.68 | AVG Volume (30 days): | 1.6M |
Analyst Decision: | Buy | Number of Analysts: | 20 |
Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
EPS: | 7.76 | EPS Growth: | -5.94 |
52 Week Low/High: | $314.93 - $406.19 | Next Earning Date: | 04-29-2025 |
Revenue: | $22,595,000,000 | Revenue Growth: | 10.23% |
Revenue Growth (this year): | 10.19% | Revenue Growth (next year): | 6.69% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Golston Allan C. | SYK | Director | Feb 18 '25 | Sell | $383.07 | 2,458 | $941,586.06 | 14,895 | |
STRYKER RONDA E | SYK | Director10% Owner | Jan 31 '25 | Sell | $393.84 | 236,000 | $92,688,579.06 | 3,707,937 | |
STRYKER RONDA E | SYK | Director10% Owner | Jan 30 '25 | Sell | $393.32 | 201,392 | $78,993,068.38 | 3,707,937 |
SYK Breaking Stock News: Dive into SYK Ticker-Specific Updates for Smart Investing
Simply Wall St.
15 hours ago
GlobeNewswire
a day ago
Zacks
7 days ago
Zacks
8 days ago
MedTech Dive
10 days ago
Zacks
13 days ago
Zacks
13 days ago
Simply Wall St.
14 days ago
The information presented on this page, "SYK Stryker Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.